EUVIMEDEUVIMED entdecken
Crossref

Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in an Experimental Autoimmune Encephalomyelitis Mouse Model

Sadhana Sharma, Sydney Risen, Vincenzo S Gilberto, Sean Boland, Anushree Chatterjee, Julie A Moreno iD, Prashant Nagpal iD

ACS Chemical Neuroscience · 2024

DOI: 10.1021/acschemneuro.4c00024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2024. Verfasst von Sadhana Sharma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sachi Bio, Colorado Technology Center, 685 S Arthur Avenue, Louisville, Colorado 80027, United States. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Biological and Physical Sciences Division, Ames Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisHumansFemaleMiceAnimalsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNeuroinflammatory DiseasesReceptors, Tumor Necrosis Factor, Type IMice, Inbred C57BL

Stichwörter der Autor:innen

autoimmune diseaseinflammasome-inhibitormultiple Sclerosisnanoligomerneuroinflammation

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinReceptors, Tumor Necrosis Factor, Type I

Autor:innen und Institutionen

  • Sachi Bio, Colorado Technology Center, 685 S Arthur Avenue, Louisville, Colorado 80027, United States.
  • Environmental & Radiological Health Sciences, and Brain Research Center, Colorado State University, Fort Collins, Colorado 80523, United States.

ORCID-Profile: Julie A Moreno, Prashant Nagpal

Förderung

  • Biological and Physical Sciences Division
  • Ames Research Center

Zitieren

APA

Sharma, S., Risen, S., Gilberto, V. S., Boland, S., Chatterjee, A., Moreno, J. A., & Nagpal, P. (2024). Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in an Experimental Autoimmune Encephalomyelitis Mouse Model. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00024

Vancouver

Sharma S, Risen S, Gilberto VS, Boland S, Chatterjee A, Moreno JA, et al. Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in an Experimental Autoimmune Encephalomyelitis Mouse Model. ACS Chemical Neuroscience. 2024. doi:10.1021/acschemneuro.4c00024

BibTeX
@article{Sharma2024,
  author = {Sharma, Sadhana and Risen, Sydney and Gilberto, Vincenzo S and Boland, Sean and Chatterjee, Anushree and Moreno, Julie A and Nagpal, Prashant},
  title = {Targeted-Neuroinflammation Mitigation Using Inflammasome-Inhibiting Nanoligomers is Therapeutic in an Experimental Autoimmune Encephalomyelitis Mouse Model},
  journal = {ACS Chemical Neuroscience},
  year = {2024},
  doi = {10.1021/acschemneuro.4c00024}
}
Kostenlos starten →